Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

Lei Deng, Lesli A. Kiedrowski, Elizabeth Ravera, Haiying Cheng, Balazs Halmos

Research output: Contribution to journalLetter

7 Scopus citations

Cite this